By Kiku Steinfeld
Chicago, Feb. 22 – Citigroup Global Markets Holdings Inc. priced $1.31 million of 0% buffer securities due March 13, 2023 linked to the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Citigroup Inc.
If the fund finishes above its initial level, the payout at maturity will be par plus 200% of the fund gain, capped at par plus 17.2%. If the fund falls by up to 10%, the payout will be par. Otherwise, investors will lose 1% for every 1% fund decline beyond 10%.
Citigroup Global Markets Inc. is the underwriter.
| Issuer: | Citigroup Global Markets Holdings Inc.
|
| Guarantor: | Citigroup Inc.
|
| Issue: | Buffer securities
|
| Underlying fund: | SPDR S&P Biotech ETF
|
| Amount: | $1,307,000
|
| Maturity: | March 13, 2023
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | Par plus 200% of any fund gain, capped at par plus 17.2%; par if fund falls by up to 10%; otherwise, 1% loss for every 1% fund decline beyond 10%
|
| Initial level: | $132.31
|
| Buffer level: | $119.079; 90% of initial level
|
| Pricing date: | Sept. 8
|
| Settlement date: | Sept. 13
|
| Underwriter: | Citigroup Global Markets Inc.
|
| Fees: | 2.1%
|
| Cusip: | 17329QQ37
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
